OASMIA PHARMACEUTICAL AB Inactive Instrument
Calendar Oasmia Pharmaceutical AB NORDIC GROWTH MARKET
Equities
OASM
SE0000722365
Chart calendar Oasmia Pharmaceutical AB
0c369cbc13.SXA0gDkDK6A-yyn8ObaxjmBPaMHPnXpqx4xdNb8nmqs.BTtnsmt1dPRxgXPLS_DDxlB_P6j9xREugN8HVsVNwMIBB1vaCm9N-Wq6ZA~33049b4fafb9c0884ad05d816f737fc3
Upcoming events on Oasmia Pharmaceutical AB
Past events on Oasmia Pharmaceutical AB
| 2024-05-23 04:00 am | Annual General Meeting |
| 2024-05-23 02:00 am | Q1 2024 Earnings Release |
| 2024-02-21 | Q4 2023 Earnings Release |
| 2023-11-15 | Q3 2023 Earnings Release |
| 2023-08-23 | Q2 2023 Earnings Release |
| 2023-05-25 03:00 am | Annual General Meeting |
| 2023-05-25 02:00 am | Q1 2023 Earnings Release |
| 2023-02-23 02:00 am | FY 2022 Earnings Release |
| 2022-11-17 04:00 am | Q3 2022 Earnings Call |
| 2022-11-17 02:00 am | Q3 2022 Earnings Release |
| 2022-08-25 04:00 am | Interim 2022 Earnings Call |
| 2022-08-25 02:00 am | Interim 2022 Earnings Release |
| 2022-05-25 04:00 am | Q1 2022 Earnings Call |
| 2022-05-25 02:00 am | Q1 2022 Earnings Release |
| 2022-05-24 | Annual General Meeting |
| 2022-05-03 | Anglonordic Life Science Conference |
| 2022-03-22 | Vator Swiss Nordic BIO |
| 2022-03-13 | Investor Meeting |
| 2022-02-28 | Sachs Associates European Life Sciences CEO Forum |
| 2022-02-24 04:00 am | FY 2021 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,98 12,1 -83.64% | 0,00 | 26,2 16,5 58.74% | 1,02 2,00 -49.25% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -114 -88,4 -28.41% | 0,00 | -99,8 -147 32.31% | -90,5 -91,0 0.52% | -34,0 |
|
EBIT Million SEK | Released Forecast Spread | -120 -95,0 -26.46% | 0,00 | -129 -176 26.95% | -165 -164 -0.61% | -37,0 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -138 -113 -22.29% | 0,00 | -133 -179 25.85% | -167 -167 0.19% | -36,0 |
|
Net income Million SEK | Released Forecast Spread | -171 -146 -17.36% | -10,5 | -133 -179 25.85% | -167 -167 0.19% | -36,0 |
|
EPS SEK | Released Forecast Spread | -0,88 -0,58 -51.39% | -0,03 | -0,30 -0,40 25% | -0,34 -0,31 -9.68% | -0,07 |
| Announcement Date | 28/06/19 | 19/08/20 | 24/02/22 | 23/02/23 | - |
| 2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
| 2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
| 2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
| 2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
| 2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
| 2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oasmia Pharmaceutical AB
| 2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
| 2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
